Author:
Klyuchnikov E,Bacher U,Woo Ahn K,Carreras J,Kröger N M,Hari P N,Ku G H,Ayala E,Chen A I,Chen Y-B,Cohen J B,Freytes C O,Gale R P,Kamble R T,Kharfan-Dabaja M A,Lazarus H M,Martino R,Mussetti A,Savani B N,Schouten H C,Usmani S Z,Wiernik P H,Wirk B,Smith S M,Sureda A,Hamadani M
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference38 articles.
1. Nathwani BN, Harris NL, Weisenberger DD Follicular lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours. Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008, pp 162–167.
2. Bilalovic N, Blystad AK, Golouh R, Nesland JM, Selak I, Trinh D et al. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol 2004; 121: 34–42.
3. Pruneri G, Valentini S, Fabris S, Del Curto B, Laszlo D, Bertolini F et al. Cyclin D3 immunoreactivity in follicular lymphoma is independent of the t(6;14)(p21.1;q32.3) translocation or cyclin D3 gene amplification and is correlated with histologic grade and Ki-67 labeling index. Int J Cancer 2004; 112: 71–77.
4. Guo Y, Karube K, Kawano R, Kawano R, Yamaguchi T, Suzumiya J et al. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 2005; 19: 1058–1063.
5. Naresh KN . MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes. Haematologica 2007; 92: 267–268.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献